Not Yet Recruiting
A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.
NCT07164534
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
- Locations
-
Not specified